Clinical Trial Update: Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery

View source ↗

Summary

This clinical trial evaluated whether erythropoietin can serve as a biomarker to indicate possible acute kidney injury after cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University of Michigan | Conditions: Erythropoietin, Acute Kidney Injury | Status: COMPLETED